REG - BkofA Merrill Lynch Willis Towers Watson - Form 38.5 (b) - Willis Towers Watson Plc
RNS Number : 9557BBank of America Merrill Lynch15 June 2021FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT
RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNIZED INTERMEDIARY
STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
1.
KEY INFORMATION
Name of exempt principal trader
Bank of America, N.A., Proprietary
Company dealt in
Willis Towers Watson PLC
Class of relevant security to which the
dealings being disclosed relate(Note 1)Common - IE00BDB6Q211
Date of dealing
14/06/2021
2.
INTERESTS AND SHORT POSITIONS
(a)
Interests and short positions (following dealing) in the class of relevant security
dealt in (Note 2)
Class of relevant security: Common
IE00BDB6Q211
Long
Short
Number
%
Number
%
(1)
Relevant securities
109,210
0.085%
41,117
0.032 %
(2)
Derivatives (other than options):
199,477
0.155%
132,050
0.102%
(3)
Options and agreements to purchase/sell:
0
0%
0
0%
Total
308,687
0.239%
173,167
0.134%
(b)
Interests and short positions in relevant securities of the company, other than the
class dealt in (Note 2)
Class of relevant security:
Long
Short
Number
%
Number
%
(1)
Relevant securities
0
0%
0
0%
(2)
Derivatives (other than options):
0
0%
0
0%
(3)
Options and agreements to purchase/sell:
0
0%
0
0%
Total
0
0%
0
0%
3.
DEALINGS (Note 3)
(a)
Purchases and sales
Purchase/sale
Number of relevant securities
Price per unit (Note 4)
Purchase
905
256.12 USD
Purchase
11
257.49 USD
Purchase/sale
Number of relevant securities
Price per unit (Note 4)
Sale
36
255.83 USD
Sale
6
256.03 USD
Sale
30
256.12 USD
Sale
11
257.49 USD
(b)
Derivatives transactions (other than options transactions)
Product name,
e.g. CFDNature of transaction
(Note 5)Number of relevant securities
(Note 6)Price per unit
(Note 4)N/A
N/A
N/A
N/A
(c)
Options transactions in respect of existing relevant securities
(i)
Writing, selling, purchasing or varying
Product name, e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise price
Type, e.g. American, European etc
Expiry date
Option money paid/ received per unit (Note 4)
N/A
N/A
N/A
N/A
N/A
N/A
N/A
(ii)
Exercising
Product name,
e.g. call optionNumber of securities
Exercise price per
unit (Note 4)N/A
N/A
N/A
(d)
Other dealings (including transactions in respect of new securities) (Note 3)
Nature or transaction
(Note 7)Details
Price per unit
(if applicable) (Note 4)N/A
N/A
N/A
4.
OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting rights
or future acquisition or disposal of any relevant securities to which any derivative
referred to on this form is referenced. If none, this should be stated.None
Is a Supplemental Form 38.5(b) attached? (Note 8)
No
Date of disclosure
15/06/2021
Contact name
Tolu Tade
Telephone number
+44207 996 3410
Name of offeree/offeror with which connected
Willis Towers Watson PLC
Nature of connection (Note 9)
Advisor to - Willis Towers Watson PLC
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDISEEAEKSFFKFEFA
Recent news on Willis Towers Watson
See all newsREG - Coventry BuildingSoc - Non-Executive Director Appointment
AnnouncementREG - Onward Opportunities - Admission to AIM and First Day of Dealings
AnnouncementRCS - Brit Utd ProvAscBUPA - Directorate Change - Nicholas Lyons
AnnouncementREG - BkofA Merrill Lynch Willis Towers Watson - Form 38.5 (a) - Willis Towers Watson Plc
AnnouncementREG - BkofA Merrill Lynch Willis Towers Watson - Form 38.5 (b) - Willis Towers Watson Plc
Announcement